Inflammatory Mediators of Asthma: An Update
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 50 (4) , 515-596
- https://doi.org/10.1016/s0031-6997(24)01381-4
Abstract
No abstract availableThis publication has 1444 references indexed in Scilit:
- Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind TrialArchives of internal medicine (1960), 1998
- Interleukin‐17 up‐regulation of nitric oxide production in human osteoarthritis cartilageArthritis & Rheumatism, 1997
- Leukotrienes in AsthmaArchives of internal medicine (1960), 1996
- CYTOKINE PRODUCTION BY CELL CULTURES FROM BRONCHIAL SUBEPITHELIAL MYOFIBROBLASTSThe Journal of Pathology, 1996
- Effect of Treatment With Zileuton, a 5-Lipoxygenase Inhibitor, in Patients With AsthmaPublished by American Medical Association (AMA) ,1996
- Distribution of vasoactives intestinal peptide‐ and substance P‐containing nerves originating from neurons of airway ganglia in cat bronchiJournal of Comparative Neurology, 1991
- Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generationEuropean Journal of Immunology, 1990
- Endogenous interleukin 6 plays an obligatory role in interleukin 4‐dependent human IgE synthesisEuropean Journal of Immunology, 1989
- B cell growth and differentiation activity of interleukin‐hp1 and related murine plasmacytoma growth factors. synergy with interleukin 1European Journal of Immunology, 1988
- Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20)European Journal of Immunology, 1986